03.06.25|Meir Orbach, Sophie ShulmanThe collapse of the classic startup playbook is forcing a fundamental reinvention.
24.03.21|Golan HazaniSenior executives at The Phoenix explain their strategy when it comes to investments in private companies and admit they missed the insurtech craze
03.08.20|Sophie ShulmanBefore joining Catalyst, Bahar-Manoah held senior management positions at Israeli plastic products company Keter and pesticide manufacturer Adama
05.11.18|Hagar RavetWhile tech companies’ choose to stay private longer, a record number of privately held growth companies now call Israel home, some with a valuation topping $1 billion
02.10.18|CTechPrivate equity deals are also picking up again after last year, with a shift from IT to healthcare, according to a new analysis by Pitchbook editor Eric Burg
19.03.18|Omer Kabir“Israel is the highest density geography in our portfolio,” Mr. Horing, co-founder and managing director at Insight Venture Partners, said at Calcalist's Mind the Tech conference in New York
05.03.18|Tofi StolerAmong those promoted is Ilan Rosen, head of HarbourVest’s Tel Aviv office
03.01.18|Tofi StolerThe investment was led by private equity firm Claridge Israel, the local branch of international firm Claridge Investment Ltd.
26.12.17|Lilach BaumerAfter payment, the private equity firm will own approximately 52% of outstanding Cyren Shares
07.11.17|Dror ReichThe private equity acquired a 21.3% stake in Nasdaq-listed Cyren for $19.6 million and plans to increase ownership by buying up to 75% of the company’s shares
15.08.17|CalcalistThe private equity firms are taking an interest in Teva's European oncology and pain treatment assets, estimated at $700 million to 1$ billion, according to a Bloomberg report